| Product Code: ETC10765665 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Serbia`s import trend for pemetrexed in the market showed a growth rate of 7.82% from 2023 to 2024, with a compound annual growth rate (CAGR) of 6.81% for the period 2020-2024. This increase can be attributed to rising demand for advanced medical treatments and improved market conditions.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Pemetrexed Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Pemetrexed Market Revenues & Volume, 2022 & 2032F |
3.3 Serbia Pemetrexed Market - Industry Life Cycle |
3.4 Serbia Pemetrexed Market - Porter's Five Forces |
3.5 Serbia Pemetrexed Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 Serbia Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2022 & 2032F |
3.7 Serbia Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2022 & 2032F |
3.8 Serbia Pemetrexed Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Serbia Pemetrexed Market Revenues & Volume Share, By Administration Route, 2022 & 2032F |
4 Serbia Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Serbia Pemetrexed Market Trends |
6 Serbia Pemetrexed Market, By Types |
6.1 Serbia Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Serbia Pemetrexed Market Revenues & Volume, By Indication, 2022 - 2032F |
6.1.3 Serbia Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2022 - 2032F |
6.1.4 Serbia Pemetrexed Market Revenues & Volume, By Mesothelioma, 2022 - 2032F |
6.1.5 Serbia Pemetrexed Market Revenues & Volume, By Breast Cancer, 2022 - 2032F |
6.1.6 Serbia Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2022 - 2032F |
6.1.7 Serbia Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2022 - 2032F |
6.2 Serbia Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Serbia Pemetrexed Market Revenues & Volume, By Antifolate, 2022 - 2032F |
6.2.3 Serbia Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2022 - 2032F |
6.2.4 Serbia Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2022 - 2032F |
6.2.5 Serbia Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2022 - 2032F |
6.2.6 Serbia Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2022 - 2032F |
6.3 Serbia Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Serbia Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2022 - 2032F |
6.3.3 Serbia Pemetrexed Market Revenues & Volume, By Immunotherapy, 2022 - 2032F |
6.3.4 Serbia Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2022 - 2032F |
6.3.5 Serbia Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2022 - 2032F |
6.3.6 Serbia Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2022 - 2032F |
6.4 Serbia Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Serbia Pemetrexed Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Serbia Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2022 - 2032F |
6.4.4 Serbia Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.4.5 Serbia Pemetrexed Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.4.6 Serbia Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.5 Serbia Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Serbia Pemetrexed Market Revenues & Volume, By Intravenous, 2022 - 2032F |
6.5.3 Serbia Pemetrexed Market Revenues & Volume, By Injection, 2022 - 2032F |
6.5.4 Serbia Pemetrexed Market Revenues & Volume, By IV Infusion, 2022 - 2032F |
6.5.5 Serbia Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2022 - 2032F |
6.5.6 Serbia Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
7 Serbia Pemetrexed Market Import-Export Trade Statistics |
7.1 Serbia Pemetrexed Market Export to Major Countries |
7.2 Serbia Pemetrexed Market Imports from Major Countries |
8 Serbia Pemetrexed Market Key Performance Indicators |
9 Serbia Pemetrexed Market - Opportunity Assessment |
9.1 Serbia Pemetrexed Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 Serbia Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2022 & 2032F |
9.3 Serbia Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2022 & 2032F |
9.4 Serbia Pemetrexed Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Serbia Pemetrexed Market Opportunity Assessment, By Administration Route, 2022 & 2032F |
10 Serbia Pemetrexed Market - Competitive Landscape |
10.1 Serbia Pemetrexed Market Revenue Share, By Companies, 2025 |
10.2 Serbia Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here